Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis

Determining a minimal important change in a disease-specific quality of life questionnaire

Elizabeth F. Juniper · Journal of Clinical Epidemiology · 1994 · 1.8K citations

Pharmacy, Health Sciences, Health Assessment +14

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis

Elizabeth F. Juniper, Gordon Guyatt · Clinical & Experimental Allergy · 1991 · 809 citations

Life Sciences, Internal Medicine, Allergy +12

Clinimetrics corner: a closer look at the minimal clinically important difference (MCID)

Alexis A. Wright, Joseph Hannon, Eric J. Hegedus et al. · Journal of Manual & Manipulative Therapy · 2012 · 554 citations · Full text

Public Health, Biostatistics, Clinical Decision Support +16

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

Stephen R. Durham, W. Emminger, Alexander Kapp et al. · Journal of Allergy and Clinical Immunology · 2012 · 519 citations

Life Sciences, Immunology, Allergy +3

Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis

Stephen R. Durham, W.H. Yang, Niels Johansen et al. · Journal of Allergy and Clinical Immunology · 2006 · 478 citations

Life Sciences, Immunology, Pharmacotherapy +16